Etiology and management of infections in chronic obstructive pulmonary disease

Clinical Pulmonary Medicine

Volumn 6, Issue 6, 1999, Pages 327-332

  Sethi, Sanjay ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Medical Research 151   (United States)

Author keywords

Acute bronchitis; Antibiotics; Chronic obstructive pulmonary disease; Haemophilus influenzae

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CHOICE; HUMAN; NONHUMAN; PATIENT CODING; SPUTUM CULTURE; TREATMENT PLANNING; VIRUS INFECTION;

EID: 0032749946     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199911000-00001     Document Type: Article

References (26)

1. Shaheen SO, Barker DJP, Shiell AW, et al. The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 1994;149: 616-9.
2. Johnston IDA, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med 1998;338:581-7.
3. Cole P. Host-microbe relationships in chronic respiratory infection. Respiration 1989;55:5-8.
4. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
5. Clementsen P, Larsen FO, Milman N, et al. Haemophilus influenzae release histamine and enhance histamine release from human bronchoalveolar cells. APMIS 1995;103:806-12.
6. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med 1969; 280:397-404.
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S120.
8. Kuklinska D, Kilian M. Relative proportions of Haemophilus species in the throat of healthy children and adults. Eur J Clin Microbiol 1984; 3:249-52.
9. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961;265:1273-8.
10. May JR. The bacteriology of chronic bronchitis. Lancet 1953;12:534-7.
11. Gump DW, Phillips CA, Forsyth BR, et al. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976;113:465-73.
12. Buscho RO, Saxtan D, Shultz PS, et al. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978;137:377-83.
13. Smith CB, Golden C, Kanner R, et al. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980;121:225-32.
14. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505.
15. Blasi F, Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993;6:19-22.
16. Miyashita N, Niki Y, Nakajima M, et al. Chlamydia pneumoniae infections in patients with diffuse panbronchiolitis and COPD. Chest 1998;114:969-71.
17. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108:43S-52S.
18. Fagon J-Y, Chastre J, Trouillet J-L, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990;142:1004-8.
19. Monso E, Ruiz J, Resell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20.
20. Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function. Chest 1998;113:1542-8.
21. Sethi S, Muscarella K, Murphy TF. Dynamics of respiratory tract colonization by nontypeable Haemophilus influenzae in patients with COPD. American Society for Microbiology General Meeting, New Orleans, LA, 1996. Abstract 185.
22. Yi K, Sethi S, Murphy T. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J Infect Dis 1997;176:1247-52.
23. Doern GV, Jones RN, Pfaller MA, et al. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 1999;43:385-9.
24. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance amount respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998;27:764-70.
25. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
26. Balter MS. Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Can Med Assoc J 1994;151(Suppl):1-23.